Inspire Medical Systems (STU:2DR) ROCE % : 8.15% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Inspire Medical Systems ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Inspire Medical Systems's annualized ROCE % for the quarter that ended in Sep. 2024 was 8.15%.

Inspire Medical Systems ROCE % Historical Data

The historical data trend for Inspire Medical Systems's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspire Medical Systems ROCE % Chart

Inspire Medical Systems Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-17.82

-24.96

-16.08

-11.49

-3.56

Inspire Medical Systems Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-9.68	20.10	-10.06	3.21	8.15

Inspire Medical Systems ROCE % Calculation

Inspire Medical Systems's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-18.254	/	( ( (533.243 - 57.76)	+	(620.636 - 71.622) )	/ 2 )
	=	-18.254	/	( (475.483	+	549.014)	/ 2 )
	=	-18.254	/	512.2485
	=	-3.56 %

Inspire Medical Systems's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	51.604	/	( ( (676.673 - 60.995)	+	(717.371 - 66.912) )	/ 2 )
	=	51.604	/	( ( 615.678	+	650.459 )	/ 2 )
	=	51.604	/	633.0685
	=	8.15 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Inspire Medical Systems (STU:2DR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Inspire Medical Systems ROCE % Related Terms

Thank you for viewing the detailed overview of Inspire Medical Systems's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Inspire Medical Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (STU:2DR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

INSP:USA 2DR:Germany

Address

5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416

Website

https://www.inspiresleep.com

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Inspire Medical Systems Headlines

No Headlines